Erste Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Hold |
|
|||||
|
2025
Q1 | $1.79M | Hold |
|
|||||
|
2024
Q4 | $1.99M | Hold |
|
|||||
|
2024
Q3 | $2.05M | Hold |
|
|||||
|
2024
Q2 | $1.59M | Hold |
|
|||||
|
2024
Q1 | $2.2M | Hold |
|
|||||
|
2023
Q4 | $1.07M | Buy |
|
|||||
|
2023
Q3 | $507K | Hold |
|
|||||
|
2023
Q2 | $805K | Hold |
|
|||||
|
2023
Q1 | $819K | Hold |
|
|||||
|
2022
Q4 | $445K | Buy |
|
|||||
|
2022
Q3 | $491K | Hold |
|
|||||
|
2022
Q2 | $373K | Hold |
|
|||||
|
2022
Q1 | $484K | Hold |
|
|||||
|
2021
Q4 | $632K | Hold |
|
|||||
|
2021
Q3 | $971K | Buy |
|
|||||
|
2021
Q2 | $960K | Hold |
|
|||||
|
2021
Q1 | $1.12M | Buy |
|
|||||
|
2020
Q4 | $1.04M | Buy |
|